Company: SHPH
Filing Date: 2025-04-04
Form Type: 8-K
Source: 0001641172-25-002757
Chunk: 0

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-04-04
Form: 8-K
Item: Item 9.01
Chunk 0
---
Item
9.01 Financial Statements and Exhibits.

(d)
Exhibits

  Exhibit      Description                                                                                                   
      No.                                                                                                                    
     10.1      Consulting Agreement, dated April 3, 2025, between Shuttle Pharmaceuticals Holdings, Inc. and IR Agency LLC.  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover                                                                                                         

   2  

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

  SHUTTLE                                                      
  By:                                 /s/                      
  Name:                               Christopher              
  Title:                              Interim                  

   3